First Time Loading...

Valeo Pharma Inc
TSX:VPH

Watchlist Manager
Valeo Pharma Inc Logo
Valeo Pharma Inc
TSX:VPH
Watchlist
Price: 0.105 CAD -8.7%
Updated: May 3, 2024

Income Statement

Earnings Waterfall
Valeo Pharma Inc

Revenue
54.3m CAD
Cost of Revenue
-42.7m CAD
Gross Profit
11.6m CAD
Operating Expenses
-29.8m CAD
Operating Income
-18.2m CAD
Other Expenses
-10.2m CAD
Net Income
-28.4m CAD

Income Statement
Valeo Pharma Inc

Rotate your device to view
Income Statement
Currency: CAD
Oct-2021 Jan-2022 Apr-2022 Jul-2022 Oct-2022 Jan-2023 Apr-2023 Jul-2023 Oct-2023 Jan-2024
Revenue
Revenue
14
N/A
16
+18%
18
+13%
18
+2%
28
+50%
37
+32%
45
+24%
53
+18%
54
+1%
54
+1%
Gross Profit
Cost of Revenue
(10)
(11)
(12)
(12)
(21)
(28)
(34)
(40)
(41)
(43)
Gross Profit
4
N/A
5
+26%
6
+19%
6
+1%
6
+5%
9
+37%
11
+32%
13
+18%
13
-3%
12
-11%
Operating Income
Operating Expenses
(17)
(21)
(24)
(25)
(25)
(27)
(29)
(31)
(30)
(30)
Selling, General & Administrative
(16)
(20)
(24)
(25)
(25)
(26)
(28)
(30)
(30)
(29)
Depreciation & Amortization
(0)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
Other Operating Expenses
0
0
0
0
0
0
0
0
0
0
Operating Income
(13)
N/A
(16)
-29%
(18)
-14%
(19)
-5%
(19)
+1%
(19)
+3%
(17)
+6%
(17)
+1%
(17)
+1%
(18)
-6%
Pre-Tax Income
Interest Income Expense
(1)
(2)
(3)
(4)
(7)
(8)
(11)
(11)
(13)
(14)
Non-Reccuring Items
(0)
0
0
0
(0)
0
0
0
0
0
Total Other Income
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
3
3
Pre-Tax Income
(14)
N/A
(18)
-30%
(22)
-18%
(23)
-8%
(27)
-15%
(27)
-1%
(29)
-5%
(30)
-4%
(28)
+7%
(28)
-2%
Net Income
Tax Provision
0
0
0
0
1
0
0
0
0
0
Income from Continuing Operations
(14)
(18)
(22)
(23)
(26)
(26)
(28)
(29)
(28)
(28)
Net Income (Common)
(14)
N/A
(18)
-30%
(22)
-18%
(23)
-8%
(26)
-10%
(26)
-1%
(28)
-5%
(29)
-4%
(28)
+3%
(28)
-2%
EPS (Diluted)
-0.2
N/A
-0.24
-20%
-0.28
-17%
-0.29
-4%
-0.32
-10%
-0.32
N/A
-0.33
-3%
-0.35
-6%
-0.32
+9%
-0.33
-3%

See Also

Discover More